Osteosarcoma and Chondrosarcoma

  • A. W. Craft
Part of the UICC International Union Against Cancer book series (1360)

Abstract

Osteosarcoma is one of the two common bone tumours which occur in childhood. Although it has been reported in a child of 3 years and can occur at almost any time during adult life, the peak age is between 10 and 20 years. Many of these tumours occurring in later life complicate Paget’s disease, which does not occur in children. The annual incidence of the tumour has been reported as 1.6–2.8 per million children under 15 years; it occurs more commonly in males (M : F ratio = 1.6 : 1).

Keywords

Creatinine Tuberculosis Oncol Radionuclide Sarcoma 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Tjalma RA (1966) Canine bone sarcoma: estimation of relative risks as a function of body size. JNCI 36: 1137–1150PubMedGoogle Scholar
  2. 2.
    Spiess H (1969) Ra244 — induced tumours in children and adults. In: Mays CW, Jee WSS, Lloyd RD, Stover BJ, Dougherty JH, Taylor GN (eds) Delayed effects of bone seeking radionuclides. University of Utah Press, Salt Lake City, pp 227–246Google Scholar
  3. 3.
    Mike V, Meadows AT, D’Angio GJ (1982) Incidence of second malignant neoplasms in children: results of an international study. Lancet 2: 1326–1331PubMedCrossRefGoogle Scholar
  4. 4.
    Abramson DH, Ellsworth RM, Zimmerman LE (1976) Nonocular cancer in retinoblastoma survivors. Trans Am Acad Ophthalmol Otolaryngol 81: OP454Google Scholar
  5. 5.
    Link M, Goorin A, Miser A, Green A, Pratt C, Belasco J, Pritchard J, Baker A, Kirkpatrick J, Ayala A, Shuster J, Abelson H, Simone J, Vietti T (1985) The role of adjuvant chemotherapy in the treatment of osteosarcoma of the extremity: Preliminary results of the multi-institutional osteosarcoma study. Proc ASCO C-924, p 237Google Scholar
  6. 6.
    Craft AW (1985) Controversies in the management of bone tumours. Cancer Surveys 3: 733–750Google Scholar
  7. 7.
    Rosen G, Caparros B, Huvos AG, Kosloff C, Nirenberg A, Cacavio A, Marcove RC, Lane JM, Mehta B, Urban C (1982) Preoperative chemotherapy for osteogenic sarcoma. Cancer 49: 1221–1230PubMedCrossRefGoogle Scholar
  8. 8.
    Winkler K, Beron G, Kotz R, Salzer-Kuntschik M, Beck J, Beck W, Brandeis W, Ebell W, Erltman R, Gobel U, Havers W, Henze G, Hinderfield L, Hocker P, Jobke A, Jurgens H, Kabisch H, Preusser P, Prindull G, Ramach W, Ritter J, Sekera J, Treuner J, Wust G, Landbeck G (1984) Neoadjuvant chemotherapy for osteogenic sarcoma: Results of a cooperative German/Austrian Study. J Clin Oncol 2: 617–624Google Scholar
  9. 9.
    Burgers JMV, Voûte PA, Van Glabbeke M (1985) Adjuvant chemotherapy for osteosarcoma of the limbs: Trial 20781 of the SIOP and EORTC Radiotherapy/Chemo therapy Group. In: Van Unnik (ed) The management of bone and soft tissue sarcomas. Raven, New York (in press)Google Scholar
  10. 10.
    Marcove RC, Miké V, Hajek JV, Levin AG, Hutter RVP (1970) Osteogenic sarcoma under the age of twenty-one. A review of one hundred and forty-five operative cases. J Bone Joint Surg [Am] 52: 411–423Google Scholar
  11. 11.
    Jaffe N, Frei E, Watts H, Traggis D (1978) High- dose methotrexate in osteogenic sarcoma: a five year experience. Cancer Treat Rep 62: 259–264PubMedGoogle Scholar
  12. 12.
    Bellani FF, Gasparini M, Gennari L, Fontanillas L, Bonnadonna G (1979) Adjuvant treatment with adriamycin in primary operable osteosarcoma. Cancer Treat Rep 63: 1621–1627Google Scholar
  13. 13.
    Ochs JJ, Freeman AI, Douglass HO Jr, Higby DS, Mindell EP, Sinks LF (1978) cw-Dichlorodiammineplatinum ( II) in advanced osteogenic sarcoma. Cancer Treat Rep 62: 239–245Google Scholar
  14. 14.
    Rosen G, Huvos A, Mosende C, Beattie EJ Jr, Exelby PR, Capparos B, Marcove RC (1978) Chemotherapy and thoracotomy for metastatic osteogenic sarcoma. A model for adjuvant chemotherapy and the rationale for the time of thoracic surgery. Cancer 41: 841–849Google Scholar
  15. 15.
    Kotz R (1983) Possibilities and limitations of limb- preserving therapy for bone tumors today. J Cancer Res Clin Oncol 106 [Suppl]: 68–76PubMedCrossRefGoogle Scholar
  16. 16.
    Kotz R, Salzer M (1982) Rotationplasty for childhood osteosarcoma of the distal part of the femur. J Bone Joint Surg [Am] 64: 959–969Google Scholar
  17. 17.
    Rosen G, Caparros B, Groshen S, Nirenberg A, Cacavio A, Marcove RC, Lane JM, Huvos AG (1984) Primary osteogenic sarcoma of the femur: a model for the use of preoperative chemotherapy in high-risk malignant tumours. Cancer Invest 2: 181–192PubMedCrossRefGoogle Scholar
  18. 18.
    Jürgens H, Kosloff C, Nirenberg A, Mehta B, Huvos AG, Rosen G (1981) Prognostic factors in the response of primary osteogenic sarcoma to preoperative chemotherapy (high dose methotrexate with citrovorum factor). Natl Cancer Inst Monogr 56: 221–226Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1986

Authors and Affiliations

  • A. W. Craft

There are no affiliations available

Personalised recommendations